Deepak Nitrite
Deepak Nitrite
ChemicalsKey Fundamentals
SmallcapSpecialty ChemicalsChemicalsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Weaknesses
2- Company has a low return on equity of 12.8% over last 3 years.
- Company might be capitalizing the interest cost
Growth Rate
AI Analysis — Bull vs Bear
Deepak Nitrite has a market cap of about ₹21,652 Cr and trades at a P/E of 27.9x and a P/B of 3.74x, with a dividend yield of 0.47%. Its long-term record is strong: 10-year sales and profit CAGRs are 19% and 24%, and the stock has compounded 29% a year over 10 years. The last three years look much weaker, with flat sales (0% CAGR), profit down at a 13% CAGR, ROE falling to 10% last year and negative stock returns over 1, 3 and 5 years.
- The 10-year record shows sustained compounding: sales grew at a 19% CAGR and profit at a 24% CAGR, which points to the company's ability to scale its chemical intermediates and phenolics businesses over a full cycle.
- TTM profit growth of 31% is well above the 3-year profit CAGR of -13%, which suggests earnings may be recovering from the recent downcycle.
- TTM sales growth of 7% compares with a 0% 3-year sales CAGR, suggesting the top line is growing again after a flat period.
- ROE averaged 20% over 10 years and 18% over 5 years, which shows the business has earned high returns on capital through past cycles, above the recent 10% level.
- The stock has compounded 29% a year over 10 years, so long-term shareholders have been rewarded even after the recent drawdown.
- After negative stock returns of -14% (1Y), -10% (3Y CAGR) and -8% (5Y CAGR), the valuation at a P/E of 27.9x has pulled back from the premium levels the stock held during its peak-growth phase.
- The 0.47% dividend yield means the company pays shareholders something while holding back most earnings for capacity expansion.
- Profit has fallen at a 13% CAGR over 3 years and a 7% CAGR over 5 years, a sustained earnings decline despite the long-term growth record.
- ROE fell to 10% last year and averaged a low 12.8% over 3 years, well below the 20% 10-year average. Returns on the expanded capital base have weakened.
- The company may be capitalising interest costs. If so, reported profit can look better than it is and true financing costs may only show up once capex projects are commissioned.
- Sales have been flat over 3 years (0% CAGR), which points to pricing pressure and weak volumes in commodity-linked chemicals such as phenol and acetone.
- At a P/B of 3.74x with ROE of 10% last year, investors are paying a premium to book value that the current return profile does not justify on its own. That assumes ROE recovers.
- A P/E of 27.9x prices in a continued earnings recovery. The 31% TTM profit growth comes off a depressed base and may not last if chemical spreads stay under pressure.
- The stock has underperformed over every recent horizon: -14% over 1 year, a -10% 3-year CAGR and a -8% 5-year CAGR, reflecting sustained weak sentiment toward the name.
- The 0.47% dividend yield offers little income support if earnings recovery or capex returns are delayed.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- ₹300 crore Dahej plant commissioned Sep 29
Deepak Chem Tech, a wholly owned subsidiary of Deepak Nitrite, commissioned a Chlorination and Specialty chemical plant at Dahej. The capex was ₹300 crore, which adds new capacity and moves the company further into specialty chemicals.
- ₹80 crore intra-group OCRPS infusion Sep 29
Deepak Phenolics, a subsidiary, bought ₹80 crore of 9% Optionally Convertible Redeemable Preference Shares in Deepak Chem Tech to strengthen its capital base. Because this is a transfer between group companies, consolidated finances are largely unaffected.
TL;DR: Deepak Nitrite is carrying out its capex plan: the ₹300 crore Dahej plant is now running, and the group is backing it with an ₹80 crore internal funding move. The news contains no direct headwinds. Still, the risks to watch are how fast the new plant ramps up, how much capacity it uses, and specialty chemical prices across the sector, none of which these articles cover. The trend looks good on execution, and future earnings will depend on how quickly the Dahej plant starts adding meaningful revenue and margin.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,768 | 1,778 | 2,009 | 2,126 | 2,167 | 2,032 | 1,903 | 2,180 | 1,890 | 1,902 | 1,975 | 2,120 | 2,578 |
| Expenses | 1,559 | 1,476 | 1,705 | 1,825 | 1,858 | 1,734 | 1,735 | 1,863 | 1,700 | 1,698 | 1,764 | 1,744 | 2,037 |
| Operating Profit | 210 | 302 | 305 | 301 | 309 | 298 | 169 | 317 | 190 | 204 | 211 | 376 | 540 |
| OPM % | 12% | 17% | 15% | 14% | 14% | 15% | 9% | 15% | 10% | 11% | 11% | 18% | 21% |
| Other Income | 32 | 17 | 14 | 99 | 19 | 21 | 21 | 23 | 25 | 20 | -4 | 7 | 14 |
| Interest | 2 | 3 | 3 | 4 | 6 | 6 | 6 | 9 | 8 | 8 | 11 | 19 | 23 |
| Depreciation | 38 | 39 | 42 | 46 | 47 | 48 | 48 | 51 | 51 | 53 | 58 | 63 | 64 |
| PBT | 202 | 277 | 274 | 349 | 275 | 264 | 135 | 279 | 155 | 163 | 138 | 301 | 468 |
| Tax % | 26% | 26% | 26% | 27% | 26% | 26% | 27% | 27% | 27% | 27% | 28% | 27% | 26% |
| Net Profit | 150 | 205 | 202 | 254 | 203 | 194 | 98 | 202 | 112 | 119 | 100 | 220 | 345 |
| EPS in Rs | 10.99 | 15.04 | 14.81 | 18.61 | 14.85 | 14.24 | 7.19 | 14.84 | 8.23 | 8.7 | 7.32 | 16.11 | 25.3 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,327 | 1,373 | 1,371 | 1,651 | 2,700 | 4,230 | 4,360 | 6,802 | 7,972 | 7,682 | 8,282 | 7,887 | 8,575 |
| Expenses | 1,187 | 1,204 | 1,231 | 1,447 | 2,278 | 3,194 | 3,108 | 5,196 | 6,680 | 6,555 | 7,187 | 6,900 | 7,243 |
| Operating Profit | 140 | 169 | 139 | 204 | 421 | 1,035 | 1,252 | 1,607 | 1,292 | 1,127 | 1,095 | 987 | 1,331 |
| OPM % | 11% | 12% | 10% | 12% | 16% | 24% | 29% | 24% | 16% | 15% | 13% | 13% | 16% |
| Other Income | 1 | 0 | 80 | 7 | 11 | 29 | 20 | 42 | 46 | 156 | 84 | 44 | 36 |
| Interest | 38 | 40 | 37 | 47 | 87 | 118 | 77 | 36 | 27 | 15 | 31 | 49 | 61 |
| Depreciation | 36 | 40 | 48 | 53 | 78 | 140 | 153 | 178 | 166 | 166 | 195 | 225 | 237 |
| PBT | 67 | 89 | 135 | 111 | 268 | 806 | 1,042 | 1,434 | 1,146 | 1,102 | 953 | 757 | 1,070 |
| Tax % | 21% | 29% | 28% | 29% | 35% | 24% | 26% | 26% | 26% | 26% | 27% | 27% | — |
| Net Profit | 53 | 63 | 96 | 79 | 174 | 611 | 776 | 1,067 | 852 | 811 | 697 | 551 | 783 |
| EPS in Rs | 5.06 | 5.39 | 7.37 | 5.79 | 12.73 | 44.8 | 56.88 | 78.2 | 62.47 | 59.45 | 51.12 | 40.36 | 57.43 |
| Div. Payout % | 20% | 22% | 16% | 22% | 16% | 10% | 10% | 9% | 12% | 13% | 15% | 19% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 21 | 23 | 26 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 | 27 |
| Reserves | 325 | 450 | 689 | 895 | 1,044 | 1,545 | 2,319 | 3,311 | 4,063 | 4,769 | 5,361 | 5,810 |
| Borrowings | 545 | 529 | 724 | 987 | 1,187 | 1,107 | 590 | 315 | 73 | 286 | 1,267 | 1,638 |
| Other Liabilities | 235 | 295 | 350 | 684 | 677 | 538 | 630 | 779 | 967 | 1,012 | 1,053 | 1,180 |
| Total Liabilities | 1,125 | 1,296 | 1,789 | 2,592 | 2,935 | 3,217 | 3,567 | 4,432 | 5,129 | 6,095 | 7,708 | 8,654 |
| Fixed Assets | 549 | 594 | 586 | 588 | 1,716 | 1,832 | 1,864 | 1,963 | 1,942 | 2,293 | 2,457 | 3,270 |
| CWIP | 44 | 36 | 349 | 955 | 34 | 172 | 220 | 122 | 301 | 774 | 1,649 | 1,828 |
| Investments | 3 | 87 | 118 | 32 | 2 | 2 | 189 | 439 | 379 | 122 | 511 | 213 |
| Other Assets | 530 | 580 | 736 | 1,018 | 1,183 | 1,210 | 1,293 | 1,908 | 2,508 | 2,907 | 3,091 | 3,343 |
| Total Assets | 1,125 | 1,296 | 1,789 | 2,592 | 2,935 | 3,217 | 3,567 | 4,432 | 5,129 | 6,095 | 7,708 | 8,654 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 108 | 167 | 49 | 183 | 60 | 765 | 1,002 | 824 | 650 | 874 | 625 | 539 |
| Investing | -89 | -169 | -353 | -525 | -163 | -428 | -396 | -424 | -276 | -717 | -1,489 | -669 |
| Financing | -22 | 4 | 305 | 345 | 96 | -338 | -599 | -386 | -359 | 44 | 806 | 193 |
| Net Cash Flow | -3 | 2 | 1 | 4 | -6 | -1 | 7 | 14 | 15 | 200 | -59 | 64 |
| Free Cash Flow | 18 | 81 | -192 | -438 | -194 | 349 | 788 | 638 | 290 | 110 | -494 | -658 |
| CFO/OP | 87 | 110 | 47 | 103 | 28 | 93 | 99 | 73 | 70 | 101 | 77 | 74 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 86 | 83 | 96 | 91 | 78 | 53 | 63 | 61 | 60 | 62 | 56 | 70 |
| Inventory Days | 47 | 54 | 75 | 118 | 94 | 63 | 64 | 53 | 62 | 54 | 59 | 57 |
| Days Payable | 48 | 59 | 95 | 176 | 106 | 57 | 72 | 46 | 46 | 38 | 33 | 35 |
| Cash Conversion Cycle | 85 | 79 | 76 | 32 | 66 | 59 | 56 | 67 | 76 | 77 | 82 | 92 |
| Working Capital Days | -3 | -28 | -49 | -29 | 35 | 33 | 57 | 57 | 70 | 70 | 64 | 61 |
| ROCE % | — | 14% | 8% | 10% | 17% | 38% | 40% | 44% | 30% | 22% | 16% | 11% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Deepak Nitrite insights
63 extracted metrics + investor summaries across FY11–FY27.
Documents
Frequently Asked Questions about Deepak Nitrite
What does Deepak Nitrite Ltd do?
Where is Deepak Nitrite Ltd (DEEPAKNTR) listed?
Which sector does Deepak Nitrite Ltd belong to?
What is the market capitalisation of Deepak Nitrite Ltd?
What is the PE ratio of Deepak Nitrite Ltd?
What is the 52-week high and low of Deepak Nitrite Ltd?
Does Deepak Nitrite Ltd pay dividends?
What is the Return on Equity (ROE) of Deepak Nitrite Ltd?
Company Information
Incorporated in 1970, Deepak Nitrite Ltd manufactures Basic Intermediates, Fine & Speciality Chemicals, Performance Products, and Phenolics[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/DEEPAKNTR.md for Deepak Nitrite Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.